Difference between revisions of "Basic Behavioral Neurology Clinical Concepts"

Line 2: Line 2:
  
 
- Alzheimer Disease Research Center (ADRC) criteria (Albert et al, 2011)
 
- Alzheimer Disease Research Center (ADRC) criteria (Albert et al, 2011)
 
+
# Concern regarding an intraindividual change in cognition
1) Concern regarding an intraindividual change in cognition
+
# Impairment in one or more cognitive domains
 
+
# Preservation of independence in functional abilities
2) Impairment in one or more cognitive domains
+
# Not demented
 
 
3) Preservation of independence in functional abilities
 
 
 
4) Not demented
 
  
  
 
- Petersen criteria (Petersen 2016)
 
- Petersen criteria (Petersen 2016)
 
+
# Memory complaints per subject and/or collateral source
1) Memory complaints per subject and/or collateral source
+
# Intact activities of daily living
 
+
# Clinical dementia rating scale of 0.5
2) Intact activities of daily living
+
# Performance on a delayed memory test that is at least one standard deviation below the mean for the subject’s age
 
 
3) Clinical dementia rating scale of 0.5
 
 
 
4) Performance on a delayed memory test that is at least one standard deviation below the mean for the subject’s age
 
  
  
 
- Epidemiology (Petersen 2016)
 
- Epidemiology (Petersen 2016)
 
+
# 15-20% of patients over the age of 60 have MCI  
1) 15-20% of patients over the age of 60 have MCI  
+
# The annual rate in which MCI progresses to dementia varies between 8% and 15% per year  
 
 
2) The annual rate in which MCI progresses to dementia varies between 8% and 15% per year  
 
  
  
 
'''Levels of Functioning''' (Salardini 2019)
 
'''Levels of Functioning''' (Salardini 2019)
 
+
* Activities of daily living: dressing, bathing, toileting, continence, transferring, eating
- Activities of daily living: dressing, bathing, toileting, continence, transferring, eating
+
* Instrumental activities of daily living: shopping, preparing food, housework, laundry, use transportation, medication compliance, handling finances
 
+
* Advanced activities of daily living: vocational skills, vocational knowledge, hobby-related mastery, music, art
- Instrumental activities of daily living: shopping, preparing food, housework, laundry, use transportation, medication compliance, handling finances
 
 
 
- Advanced activities of daily living: vocational skills, vocational knowledge, hobby-related mastery, music, art
 
  
  
Line 42: Line 29:
  
 
Cognitive or behavioral (neuropsychiatric) symptoms that:
 
Cognitive or behavioral (neuropsychiatric) symptoms that:
 
+
# Interfere with the ability to function at work or at usual activities; and
1) Interfere with the ability to function at work or at usual activities; and
+
# Represent a decline from previous levels of functioning and performing; and
 
+
# Are not explained by delirium or major psychiatric disorder.
2) Represent a decline from previous levels of functioning and performing; and
+
# Cognitive impairment is detected and diagnosed through a combination of
 
+
## History-taking from the patient and a knowledgeable informant and
3) Are not explained by delirium or major psychiatric disorder.
+
## Objective cognitive assessment, either a “bedside” mental status examination or neuropsychological testing
 
+
# The cognitive or behavioral impairment involves a minimum of two of the following domains:
4) Cognitive impairment is detected and diagnosed through a combination of
+
## Impaired ability to acquire and remember new information
 
+
## Impaired reasoning and handling of complex tasks, poor judgment
- History-taking from the patient and a knowledgeable informant and
+
## Impaired visuospatial abilities
 
+
## Impaired language functions
- Objective cognitive assessment, either a “bedside” mental status examination or neuropsychological testing
+
## Changes in personality, behavior, or comportment
 
 
5) The cognitive or behavioral impairment involves a minimum of two of the following domains:
 
 
 
- Impaired ability to acquire and remember new information
 
 
 
- Impaired reasoning and handling of complex tasks, poor judgment
 
 
 
- Impaired visuospatial abilities
 
 
 
- Impaired language functions
 
 
 
- Changes in personality, behavior, or comportment
 
  
  
Line 74: Line 49:
  
 
Alzheimer dementia
 
Alzheimer dementia
 
+
* presenting cognitive syndrome: amnestic, logopenic variant, posterior cortical atrophy
- presenting cognitive syndrome: amnestic, logopenic variant, posterior cortical atrophy
+
* risk factors: age, vascular risk factors, TBI, low education, genetics
 
+
* characteristic lesions: amyloid plaque (Abeta42), fibrillary tangles (Ptau)
- risk factors: age, vascular risk factors, TBI, low education, genetics
 
 
 
- characteristic lesions: amyloid plaque (Abeta42), fibrillary tangles (Ptau)
 
  
  
 
Vascular dementia
 
Vascular dementia
 
+
* presenting cognitive syndrome: large vessel is highly variable; small vessel presents with subcortical cognitive impairment
- presenting cognitive syndrome: large vessel is highly variable; small vessel presents with subcortical cognitive impairment
+
* risk factors: age, vascular risk factors (HTN, DM, HLD, smoking, etc.), genetics
 
+
* characteristic lesions: white matter hyperintensities, microhemorrhages, lacunes, enlarged perivascular spaces
- risk factors: age, vascular risk factors (HTN, DM, HLD, smoking, etc.), genetics
 
 
 
- characteristic lesions: white matter hyperintensities, microhemorrhages, lacunes, enlarged perivascular spaces
 
  
  
 
Frontotemporal dementia
 
Frontotemporal dementia
 
+
* presenting cognitive syndrome: language variant - nfPPA (mostly tau), SD (mostly TDP), lvPPA (AD > FTLD); behavioral variant - TDP or tau
- presenting cognitive syndrome: language variant - nfPPA (mostly tau), SD (mostly TDP), lvPPA (AD > FTLD); behavioral variant - TDP or tau
+
* risk factors: environmental factors, genetics
 
+
* characteristic lesions: Tau (Pick’s disease, FTDP-17), TDP-43 (various types including ALS-FTLD), FUS
- risk factors: environmental factors, genetics
 
 
 
- characteristic lesions: Tau (Pick’s disease, FTDP-17), TDP-43 (various types including ALS-FTLD), FUS
 
  
  
 
Parkinson disease dementia
 
Parkinson disease dementia
 
+
* presenting cognitive syndrome: subcortical dementia
- presenting cognitive syndrome: subcortical dementia
+
* risk factors: TBI, family history of PD, environmental pesticides
 
+
* characteristic lesions: alpha-synuclein predominantly in subcortical structures
- risk factors: TBI, family history of PD, environmental pesticides
 
 
 
- characteristic lesions: alpha-synuclein predominantly in subcortical structures
 
  
  
 
Lewy body dementia
 
Lewy body dementia
 
+
* presenting cognitive syndrome: hallucinations, fluctuation in cognition and level of alertness, Parkinsonism, visuospatial problems
- presenting cognitive syndrome: hallucinations, fluctuation in cognition and level of alertness, Parkinsonism, visuospatial problems
+
* risk factors: family history of PD, susceptibility genes (APOE4), low education, vascular risk factors, depression and anxiety. Protective: smoking, history of cancer
 
+
* characteristic lesions: alpha-synuclein predominantly in cortical area, high degree of coexistence of amyloid pathology
- risk factors: family history of PD, susceptibility genes (APOE4), low education, vascular risk factors, depression and anxiety. Protective: smoking, history of cancer
 
 
 
- characteristic lesions: alpha-synuclein predominantly in cortical area, high degree of coexistence of amyloid pathology
 
  
  
 
Progressive supranuclear palsy
 
Progressive supranuclear palsy
 
+
* presenting cognitive syndrome: slow vertical saccade, gait instability, Parkinsonism
- presenting cognitive syndrome: slow vertical saccade, gait instability, Parkinsonism
+
* risk factors: not well understood
 
+
* characteristic lesions: tufted astrocytes, tau and neurodegeneration in brainstem and basal ganglia
- risk factors: not well understood
 
 
 
- characteristic lesions: tufted astrocytes, tau and neurodegeneration in brainstem and basal ganglia
 
  
  
 
Corticobasal degeneration
 
Corticobasal degeneration
 +
* presenting cognitive syndrome: asymmetrical apraxia, asymmetrical dystonia or myoclonus, and Parkinsonism
 +
* risk factors: not well understood
 +
* characteristic lesions: achromatic ballooned neurons, 4R tau mostly, astrocytic plaques, parietal and temporal atrophy
  
- presenting cognitive syndrome: asymmetrical apraxia, asymmetrical dystonia or myoclonus, and Parkinsonism
 
 
- risk factors: not well understood
 
 
- characteristic lesions: achromatic ballooned neurons, 4R tau mostly, astrocytic plaques, parietal and temporal atrophy
 
  
 
== References ==
 
== References ==

Revision as of 09:42, 13 June 2021

Mild cognitive impairment definitions

- Alzheimer Disease Research Center (ADRC) criteria (Albert et al, 2011)

  1. Concern regarding an intraindividual change in cognition
  2. Impairment in one or more cognitive domains
  3. Preservation of independence in functional abilities
  4. Not demented


- Petersen criteria (Petersen 2016)

  1. Memory complaints per subject and/or collateral source
  2. Intact activities of daily living
  3. Clinical dementia rating scale of 0.5
  4. Performance on a delayed memory test that is at least one standard deviation below the mean for the subject’s age


- Epidemiology (Petersen 2016)

  1. 15-20% of patients over the age of 60 have MCI
  2. The annual rate in which MCI progresses to dementia varies between 8% and 15% per year


Levels of Functioning (Salardini 2019)

  • Activities of daily living: dressing, bathing, toileting, continence, transferring, eating
  • Instrumental activities of daily living: shopping, preparing food, housework, laundry, use transportation, medication compliance, handling finances
  • Advanced activities of daily living: vocational skills, vocational knowledge, hobby-related mastery, music, art


Dementia definition (McKhann 2011)

Cognitive or behavioral (neuropsychiatric) symptoms that:

  1. Interfere with the ability to function at work or at usual activities; and
  2. Represent a decline from previous levels of functioning and performing; and
  3. Are not explained by delirium or major psychiatric disorder.
  4. Cognitive impairment is detected and diagnosed through a combination of
    1. History-taking from the patient and a knowledgeable informant and
    2. Objective cognitive assessment, either a “bedside” mental status examination or neuropsychological testing
  5. The cognitive or behavioral impairment involves a minimum of two of the following domains:
    1. Impaired ability to acquire and remember new information
    2. Impaired reasoning and handling of complex tasks, poor judgment
    3. Impaired visuospatial abilities
    4. Impaired language functions
    5. Changes in personality, behavior, or comportment


Epidemiology: 70-80% of dementia is contributable to Alzheimer’s pathology, vascular disease, or some combination of the two; Lewy body disease contributes to 5%; the rest includes a large number of pathologies with lower prevalence (McKhann 2011)


Basic Overview of Dementias (McKhann 2011)

Alzheimer dementia

  • presenting cognitive syndrome: amnestic, logopenic variant, posterior cortical atrophy
  • risk factors: age, vascular risk factors, TBI, low education, genetics
  • characteristic lesions: amyloid plaque (Abeta42), fibrillary tangles (Ptau)


Vascular dementia

  • presenting cognitive syndrome: large vessel is highly variable; small vessel presents with subcortical cognitive impairment
  • risk factors: age, vascular risk factors (HTN, DM, HLD, smoking, etc.), genetics
  • characteristic lesions: white matter hyperintensities, microhemorrhages, lacunes, enlarged perivascular spaces


Frontotemporal dementia

  • presenting cognitive syndrome: language variant - nfPPA (mostly tau), SD (mostly TDP), lvPPA (AD > FTLD); behavioral variant - TDP or tau
  • risk factors: environmental factors, genetics
  • characteristic lesions: Tau (Pick’s disease, FTDP-17), TDP-43 (various types including ALS-FTLD), FUS


Parkinson disease dementia

  • presenting cognitive syndrome: subcortical dementia
  • risk factors: TBI, family history of PD, environmental pesticides
  • characteristic lesions: alpha-synuclein predominantly in subcortical structures


Lewy body dementia

  • presenting cognitive syndrome: hallucinations, fluctuation in cognition and level of alertness, Parkinsonism, visuospatial problems
  • risk factors: family history of PD, susceptibility genes (APOE4), low education, vascular risk factors, depression and anxiety. Protective: smoking, history of cancer
  • characteristic lesions: alpha-synuclein predominantly in cortical area, high degree of coexistence of amyloid pathology


Progressive supranuclear palsy

  • presenting cognitive syndrome: slow vertical saccade, gait instability, Parkinsonism
  • risk factors: not well understood
  • characteristic lesions: tufted astrocytes, tau and neurodegeneration in brainstem and basal ganglia


Corticobasal degeneration

  • presenting cognitive syndrome: asymmetrical apraxia, asymmetrical dystonia or myoclonus, and Parkinsonism
  • risk factors: not well understood
  • characteristic lesions: achromatic ballooned neurons, 4R tau mostly, astrocytic plaques, parietal and temporal atrophy


References

Albert, M. S. et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7, 270–279 (2011) https://pubmed.ncbi.nlm.nih.gov/21514249/

McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7, 263–269 (2011). https://pubmed.ncbi.nlm.nih.gov/21514250/

Petersen, R. C. Mild Cognitive Impairment. Continuum 22, 404–18 (2016) https://pubmed.ncbi.nlm.nih.gov/27042901/

Salardini, A. An Overview of Primary Dementias as Clinicopathological Entities. Semin. Neurol. 39, 153–166 (2019). https://pubmed.ncbi.nlm.nih.gov/30925609/